MicroRNA (miRNA) Market Size, Share, Growth, and Industry Analysis, By Type (Sample Collection, miRNA cDNA Synthesis, Profiling & Purification, Detection, Functional Studies), By Application (Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global MicroRNA (miRNA) Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 MicroRNA (miRNA) Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 MicroRNA (miRNA) Business Mode and Production Process
2.3.1 MicroRNA (miRNA) Business Mode Analysis
2.3.2 Production Process Analysis
2.4 MicroRNA (miRNA) Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of MicroRNA (miRNA)
2.4.2 Raw Material Cost of MicroRNA (miRNA)
2.4.3 Labor Cost of MicroRNA (miRNA)
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global MicroRNA (miRNA) Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global MicroRNA (miRNA) Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global MicroRNA (miRNA) Price by Manufacturer (2021-2026)
4.4 MicroRNA (miRNA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of MicroRNA (miRNA), Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of MicroRNA (miRNA), Product Offered and Application
4.7 MicroRNA (miRNA) Market Competitive Situation and Trends
4.7.1 MicroRNA (miRNA) Market Concentration Rate
4.7.2 Global Top 3 and Top 6 MicroRNA (miRNA) Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global MicroRNA (miRNA) Market Historical Development by Geographic Region (2021-2026)
5.1 Global MicroRNA (miRNA) Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global MicroRNA (miRNA) Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America MicroRNA (miRNA) Market Status by Country (2021-2026)
5.3.1 North America MicroRNA (miRNA) Sales Volume by Country (2021-2026)
5.3.2 North America MicroRNA (miRNA) Revenue by Country (2021-2026)
5.3.3 United States MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe MicroRNA (miRNA) Market Status by Country (2021-2026)
5.4.1 Europe MicroRNA (miRNA) Sales Volume by Country (2021-2026)
5.4.2 Europe MicroRNA (miRNA) Revenue by Country (2021-2026)
5.4.3 Germany MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific MicroRNA (miRNA) Market Status by Country (2021-2026)
5.5.1 Asia Pacific MicroRNA (miRNA) Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific MicroRNA (miRNA) Revenue by Country (2021-2026)
5.5.3 China MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America MicroRNA (miRNA) Market Status by Country (2021-2026)
5.6.1 Latin America MicroRNA (miRNA) Sales Volume by Country (2021-2026)
5.6.2 Latin America MicroRNA (miRNA) Revenue by Country (2021-2026)
5.6.3 Mexico MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa MicroRNA (miRNA) Market Status by Country (2021-2026)
5.7.1 Middle East and Africa MicroRNA (miRNA) Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa MicroRNA (miRNA) Revenue by Country (2021-2026)
5.7.3 GCC MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa MicroRNA (miRNA) Sales Volume, Revenue and Growth (2021-2026)

6 Global MicroRNA (miRNA) Market Historical Development by Product Type (2021-2026)
6.1 MicroRNA (miRNA) Definition by Type
6.2 Global MicroRNA (miRNA) Historical Sales Volume by Product Type (2021-2026)
6.3 Global MicroRNA (miRNA) Historical Revenue by Product Type (2021-2026)
6.4 Global MicroRNA (miRNA) Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Sample Collection (2021-2026)
6.5.2 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of miRNA cDNA Synthesis (2021-2026)
6.5.3 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Profiling & Purification (2021-2026)
6.5.4 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Detection (2021-2026)
6.5.5 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Functional Studies (2021-2026)

7 Global MicroRNA (miRNA) Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global MicroRNA (miRNA) Historical Sales Volume by End User (2021-2026)
7.3 Global MicroRNA (miRNA) Historical Revenue by End User (2021-2026)
7.4 Global MicroRNA (miRNA) Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Cancer (2021-2026)
7.5.2 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Infectious Diseases (2021-2026)
7.5.3 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Immunological Disorder (2021-2026)
7.5.4 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Cardiovascular Disease (2021-2026)
7.5.5 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Neurological Disease (2021-2026)
7.5.6 Global MicroRNA (miRNA) Historical Sales Volume, Revenue and Growth Rate of Others (2021-2026)

8 Leading Companies Profiles
8.1 NanoString Technologies Inc.
8.1.1 NanoString Technologies Inc. Corporation Information
8.1.2 NanoString Technologies Inc. - MicroRNA (miRNA) Product Portfolio and Specification
8.1.3 NanoString Technologies Inc. Performance Analysis (2021-2026)
8.1.4 NanoString Technologies Inc. Business and Markets Served
8.1.5 NanoString Technologies Inc. Recent Developments
8.2 BioGenex
8.2.1 BioGenex Corporation Information
8.2.2 BioGenex - MicroRNA (miRNA) Product Portfolio and Specification
8.2.3 BioGenex Performance Analysis (2021-2026)
8.2.4 BioGenex Business and Markets Served
8.2.5 BioGenex Recent Developments
8.3 Quantabio
8.3.1 Quantabio Corporation Information
8.3.2 Quantabio - MicroRNA (miRNA) Product Portfolio and Specification
8.3.3 Quantabio Performance Analysis (2021-2026)
8.3.4 Quantabio Business and Markets Served
8.3.5 Quantabio Recent Developments
8.4 QIAGEN (Exiqon)
8.4.1 QIAGEN (Exiqon) Corporation Information
8.4.2 QIAGEN (Exiqon) - MicroRNA (miRNA) Product Portfolio and Specification
8.4.3 QIAGEN (Exiqon) Performance Analysis (2021-2026)
8.4.4 QIAGEN (Exiqon) Business and Markets Served
8.4.5 QIAGEN (Exiqon) Recent Developments
8.5 Synlogic
8.5.1 Synlogic Corporation Information
8.5.2 Synlogic - MicroRNA (miRNA) Product Portfolio and Specification
8.5.3 Synlogic Performance Analysis (2021-2026)
8.5.4 Synlogic Business and Markets Served
8.5.5 Synlogic Recent Developments
8.6 GeneCopoeia Inc.
8.6.1 GeneCopoeia Inc. Corporation Information
8.6.2 GeneCopoeia Inc. - MicroRNA (miRNA) Product Portfolio and Specification
8.6.3 GeneCopoeia Inc. Performance Analysis (2021-2026)
8.6.4 GeneCopoeia Inc. Business and Markets Served
8.6.5 GeneCopoeia Inc. Recent Developments
8.7 New England Biolabs
8.7.1 New England Biolabs Corporation Information
8.7.2 New England Biolabs - MicroRNA (miRNA) Product Portfolio and Specification
8.7.3 New England Biolabs Performance Analysis (2021-2026)
8.7.4 New England Biolabs Business and Markets Served
8.7.5 New England Biolabs Recent Developments
8.8 SeqMatic LLC
8.8.1 SeqMatic LLC Corporation Information
8.8.2 SeqMatic LLC - MicroRNA (miRNA) Product Portfolio and Specification
8.8.3 SeqMatic LLC Performance Analysis (2021-2026)
8.8.4 SeqMatic LLC Business and Markets Served
8.8.5 SeqMatic LLC Recent Developments
8.9 Thermofisher Scientific (Life Technologies)
8.9.1 Thermofisher Scientific (Life Technologies) Corporation Information
8.9.2 Thermofisher Scientific (Life Technologies) - MicroRNA (miRNA) Product Portfolio and Specification
8.9.3 Thermofisher Scientific (Life Technologies) Performance Analysis (2021-2026)
8.9.4 Thermofisher Scientific (Life Technologies) Business and Markets Served
8.9.5 Thermofisher Scientific (Life Technologies) Recent Developments
8.10 Agilent Technologies
8.10.1 Agilent Technologies Corporation Information
8.10.2 Agilent Technologies - MicroRNA (miRNA) Product Portfolio and Specification
8.10.3 Agilent Technologies Performance Analysis (2021-2026)
8.10.4 Agilent Technologies Business and Markets Served
8.10.5 Agilent Technologies Recent Developments
8.11 Dharmacon (Horizon Discovery Group)
8.11.1 Dharmacon (Horizon Discovery Group) Corporation Information
8.11.2 Dharmacon (Horizon Discovery Group) - MicroRNA (miRNA) Product Portfolio and Specification
8.11.3 Dharmacon (Horizon Discovery Group) Performance Analysis (2021-2026)
8.11.4 Dharmacon (Horizon Discovery Group) Business and Markets Served
8.11.5 Dharmacon (Horizon Discovery Group) Recent Developments
8.12 Merck KGaA
8.12.1 Merck KGaA Corporation Information
8.12.2 Merck KGaA - MicroRNA (miRNA) Product Portfolio and Specification
8.12.3 Merck KGaA Performance Analysis (2021-2026)
8.12.4 Merck KGaA Business and Markets Served
8.12.5 Merck KGaA Recent Developments

9 Global MicroRNA (miRNA) Market Forecast by Product Type and End User (2026-2034)
9.1 Global MicroRNA (miRNA) Market Forecast by Product Type (2026-2034)
9.1.1 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Sample Collection (2026-2034)
9.1.2 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of miRNA cDNA Synthesis (2026-2034)
9.1.3 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Profiling & Purification (2026-2034)
9.1.4 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Detection (2026-2034)
9.1.5 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Functional Studies (2026-2034)
9.2 Global MicroRNA (miRNA) Market Forecast by End User (2026-2034)
9.2.1 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Cancer (2026-2034)
9.2.2 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Infectious Diseases (2026-2034)
9.2.3 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Immunological Disorder (2026-2034)
9.2.4 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Cardiovascular Disease (2026-2034)
9.2.5 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Neurological Disease (2026-2034)
9.2.6 Global MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth Rate of Others (2026-2034)

10 Global MicroRNA (miRNA) Market Forecast by Geographic Region (2026-2034)
10.1 Global MicroRNA (miRNA) Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa MicroRNA (miRNA) Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer